Harbour Antibodies BV, headquartered in Newton, MA, is a leading biotechnology company specializing in the generation of human antibodies for therapeutic purposes. With a team of experienced scientists and researchers, the company focuses on developing innovative antibody-based therapies to address various diseases and medical conditions. Harbour Antibodies BV is committed to providing high-quality and effective antibody solutions to improve patient outcomes.
Through its subsidiaries, Harbour Antibodies H2L2 BV and Harbour Antibodies HCAb BV, the company leverages advanced science and technology to develop and evaluate human antibodies. With a strong emphasis on research and development, Harbour Antibodies BV collaborates with partners and engages in strategic partnerships to further enhance its antibody discovery capabilities. Committed to privacy and security, the company ensures the protection of personal information obtained through its website, maintaining the trust and confidentiality of its users.
Generated from the website